{
  "Q0": "Whole Exome Sequencing (WES)",
  "Q1": "Not specified",
  "Q2": "Not specified",
  "Q3": "Yes",
  "Q4": "No",
  "Q5": "Yes",
  "Q6": "No",
  "Q7": "Yes",
  "Q8": "No",
  "Q9": "Yes",
  "Q10": "No",
  "Q10_followup": "Diagnostic",
  "Q11": "Not specified",
  "Q12": "No",
  "Q13": "Not specified",
  "Q14": "Not listed",
  "Q15": "No",
  "Q16": "Yes",
  "Q17": "Based on the available policy information, the claim should include documentation of the patient's clinical features (neurodevelopmental delay and seizures), family history (brother with autism spectrum disorder), prior negative genetic testing (chromosomal microarray), and a clear statement of how the WES results will directly impact treatment decisions for the patient. The claim should be submitted with appropriate CPT codes for whole exome sequencing, though specific codes are not listed in the provided policy."
}